Omid Seidizadeh/LinkedIn
Oct 23, 2025, 06:48
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”Happy to share our new publication in RPTH Journal
Our study integrates clinical, biochemical, and structural data to uncover how A2 domain variants drive disease through impaired multimerization, altered proteolysis, and increased clearance.
A great collaboration with Dr. Luca Mollica and the team!”
Read the full article in RPTH.
Article: Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
Authors: Omid Seidizadeh, Luca Mollica, Davide Giana, Luciano Baronciani, Paola Colpani, Lea Sicuro, Andrea Cairo, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 13:22Nicholas Lee: Honored to Join ASH CRTI Program for Aplastic Anemia Research
-
May 6, 2026, 13:16Mehari Gebreyohanns: Transition from Alteplase to Tenecteplase Is Full Steam Ahead in Texas
-
May 6, 2026, 12:53Masoabi Sefojane: In Africa 88% of Hemophilia Remains Undiagnosed
-
May 6, 2026, 12:36Alan Nurden: CRISPR-Mediated Megakaryocyte Modeling in Glanzmann Thrombasthenia
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study